Clinical trial · Interventional
Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction
Evaluation of a Multifaceted Vaginal Renewal™ Program Utilizing Vibrating Wands in Gynecologic Cancer Patients Experiencing Sexual Dysfunction: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Slow accrual
Summary
Brief summary (as posted)
This is a randomized controlled trial designed to evaluate the effect of the Vaginal Renewal™ Program (VRP), consisting of the use of a vibrating vaginal wand, manual massage and a water based lubricant, on sexual dysfunction, compared to the current standard care for women with no evidence of disease after treatment for gynecologic cancers. In the University of Wisconsin gynecologic oncology and radiation oncology clinics, patients are generally asked about sexual function. Those women who report sexual dysfunction will be given the option to enroll in the study. After enrollment, the Female Sexual Function Index (FSFI) and other quality of life surveys will be administered at baseline. The participants will be randomized to either the control arm, composed of standard of care therapy for the physical components of sexual dysfunction, or the experimental arm (VRP). Throughout the study, the participants will undergo physical exams to assess the rate of improvement in their comfort with pelvic exams and changes in vaginal length. They will also be evaluated with the FSFI, Marinoff Scale for Dyspareunia, and Functional Assessment of Cancer Therapy-General (FACT-G) surveys at the end of the study to assess the magnitude of improvement in sexual function and quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sexual Dysfunction, Physiological | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Vaginal Dilator | Device | — | UNRESOLVED |
| Vaginal Renewal Program | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Vaginal Renewal Program
- interventionNames
- Device: Vaginal Renewal Program
- type
- ACTIVE_COMPARATOR
- label
- Standard of care
- description
- This will consist of still vaginal dilator and/or lubricant.
- interventionNames
- Device: Vaginal Dilator
Primary outcomes (1)
- measure
- Change From Baseline in Female Sexual Function Index (FSFI) Score at 6 Months
- timeFrame
- At baseline and 6 months
- description
- Female Sexual Function Index (FSFI), uses a 19-item sexual functioning questionnaire to rate sexual function between 2.0 and 36.0, where 2.0 is low sexual function and 36.0 is high sexual function. Difference in FSFI scores are reported.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥18 * History of a gynecologic cancer * No evidence of disease at time of inclusion in the study * Postmenopausal (either surgical or natural menopause) * Self report of sexual dysfunction that did not predate cancer diagnosis * Suspected physical component to sexual dysfunction with the participant, not sexual partner * Desire to improve sexual function * ECOG Performance status score of 2 or better * Six months or greater from last surgical and/or radiation treatment Exclusion Criteria: * History of sexual reassignment * Presence of vaginal fistula * Does not desire to improve sexual function * Already using the vaginal renewal program * Not fluent in English * Incarceration
References
Publications (0)
Data not yet available